SERAFIT absorbable violet (3/0) DS-18 needle of 70 CM box of 24 sutures - Serag & Wiessner (6O203214) - Delynov

What is SERAFIT violet absorbable (3/0)?

SERAFIT by the brand Serag-Wiessner is a synthetic absorbable suture in the form of a braided multifilament. This Class III device is composed of a homopolymer of glycolic acid, which may be coated with calcium stearate and polycaprolactone to improve tissue passage. Presented in 3/0 gauge with a 70cm thread, it is specifically designed to offer high flexibility and knotting security. Its packaging in boxes of 24 sutures meets the needs of specialized oral surgery practices. This material is identified under reference 6O203214 and carries the CE1014 marking, guaranteeing its compliance with European regulatory requirements.

What are the clinical indications for SERAFIT?

SERAFIT is indicated for surgical suturing and ligations requiring an absorbable material. In clinical practice, it is particularly suitable for closing soft tissues and hollow organs. Its braided structure ensures excellent maneuverability for practitioners performing implant or periodontal surgery procedures. This dental surgery suture thread allows for effective tissue approximation during the critical healing phase. The choice of this 3/0 absorbable suture must be validated by the user based on the specific indication and the in-vivo characteristics of the material, in accordance with the surgical techniques mastered by the professional.

What are the technical characteristics of the DS-18 needle?

The DS-18 needle equipped on this Serag-Wiessner suture possesses specific properties to facilitate the surgical act. The code 'DS' designates a 3/8 circle needle with a triangular reverse cutting tip. This geometry is ideal for passing through dense tissues without causing undesirable tearing, as the cutting edge is located on the convex curvature. The number '18' indicates a body length of 18mm, offering an optimal compromise between maneuverability and accessibility in narrow areas of the oral cavity. Combined with a 70cm thread, this needle allows for fluid movements during interrupted or continuous sutures.

What are the contraindications for the use of this suture?

The use of SERAFIT is contraindicated in clinical situations requiring very long-term or permanent stability of the suture material. It must not be implanted in patients with a known allergy to glycolic acid or coating components such as calcium stearate or polycaprolactone. Furthermore, particular caution is recommended in patients with delayed healing or in tissues with poor blood supply. In these specific cases, suture extrusion or delayed absorption may occur, compromising the integrity of the surgical closure.

How does absorption occur and what are the precautions?

The absorption of SERAFIT occurs via hydrolysis in the tissues, transforming the polymer into glycolic acid which is then metabolized by the body. This process results first in a loss of tensile strength, which decreases by approximately 60% compared to its initial value after 14 days (in vitro data). The total mass loss of the thread occurs later, with absorption considered complete after approximately 90 days in-vivo. The practitioner must take this kinetics into account when choosing the material. It is advised to be vigilant when using in tissues with low blood irrigation and to always refer to the instructions to adapt the knotting technique.

Who is the manufacturer and what standards are respected?

This medical device is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer based in Germany. The SERAFIT product is a Class III medical device, meeting the strictest safety and performance standards of the European Union, as evidenced by its CE1014 marking. Each box of 24 sutures is subject to rigorous controls to guarantee the sterility and traceability of the components. As a high-tech 3/0 absorbable suture, it integrates into the care protocols of surgeons demanding certified materials for their daily interventions.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.